The move follows Sanner’s acquisition of Springboard in January 2024 and reflects the company’s goal of building a seamless, end-to-end CDMO platform spanning medical technology, pharmaceuticals, and biotechnology.
The new CFO succeeds Henrik Bøggild, who left the company after three and a half years to pursue another professional opportunity.
The device collects saliva-free exhaled breath condensate from the distal lung while minimizing contamination from the mouth, upper airways, and environment, and it integrates into standard diagnostic workflows.